These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 23223700)

  • 21. [A clinical analysis of cutaneous type dermatomyositis].
    Yu B
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Oct; 16(5):394-6. PubMed ID: 7720134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis.
    Huber AM; Lang B; LeBlanc CM; Birdi N; Bolaria RK; Malleson P; MacNeil I; Momy JA; Avery G; Feldman BM
    Arthritis Rheum; 2000 Mar; 43(3):541-9. PubMed ID: 10728746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Favorable effect of methylprednisolone pulse therapy in dysphagia and primary idiopathic polymyositis/dermatomyositis].
    Hrncír Z
    Cas Lek Cesk; 1992 Jul; 131(13):399-401. PubMed ID: 1504995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Polymyositis/dermatomyositis--clinical picture and treatment].
    Anić B; Cerovec M
    Reumatizam; 2012; 59(2):44-50. PubMed ID: 23745455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of clinical and laboratory manifestations and comorbidities in polymyositis according to gender.
    Souza FH; Levy-Neto M; Shinjo SK
    Rev Bras Reumatol; 2011; 51(5):428-83. PubMed ID: 21952995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome in juvenile dermatomyositis.
    Chowdhary V; Wakhlu A; Agarwal A; Misra R
    Indian Pediatr; 2002 Oct; 39(10):931-5. PubMed ID: 12428038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of intravenous immunoglobulin in the treatment of juvenile dermatomyositis: adverse reactions are associated with immunoglobulin A content.
    Manlhiot C; Tyrrell PN; Liang L; Atkinson AR; Lau W; Feldman BM
    Pediatrics; 2008 Mar; 121(3):e626-30. PubMed ID: 18299304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paul Coverdell National Acute Stroke Registry Surveillance - four states, 2005-2007.
    George MG; Tong X; McGruder H; Yoon P; Rosamond W; Winquist A; Hinchey J; Wall HK; Pandey DK;
    MMWR Surveill Summ; 2009 Nov; 58(7):1-23. PubMed ID: 19893482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients.
    Marie I; Menard JF; Hatron PY; Hachulla E; Mouthon L; Tiev K; Ducrotte P; Cherin P
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1748-55. PubMed ID: 20722047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sjogren's syndrome-onset lupus patients have distinctive clinical manifestations and benign prognosis: a case-control study.
    Xu D; Tian X; Zhang W; Zhang X; Liu B; Zhang F
    Lupus; 2010 Feb; 19(2):197-200. PubMed ID: 19900977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dermatomyositis and polymyositis: clinical aspects and treatment].
    Hachulla E
    Ann Med Interne (Paris); 2001 Nov; 152(7):455-64. PubMed ID: 11965087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulse versus oral methylprednisolone therapy in pemphigus vulgaris.
    Shahidi-Dadras M; Karami A; Toosy P; Shafiyan A
    Arch Iran Med; 2007 Jan; 10(1):1-6. PubMed ID: 17198445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Erythroderma and multiple cutaneous necrosis revealing a dermatomyositis].
    Maruani A; Armingaud P; Nseir A; Luthier F; Estève E
    Ann Dermatol Venereol; 2003 Mar; 130(3):353-6. PubMed ID: 12746674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.
    Dalakas MC; Illa I; Dambrosia JM; Soueidan SA; Stein DP; Otero C; Dinsmore ST; McCrosky S
    N Engl J Med; 1993 Dec; 329(27):1993-2000. PubMed ID: 8247075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anti-synthetase syndrome: anti-PL-7, anti-PL-12 and anti-EJ].
    Souza FH; Cruellas MG; Levy-Neto M; Shinjo SK
    Rev Bras Reumatol; 2013 Aug; 53(4):352-7. PubMed ID: 24217667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical spectrum, presentation, and risk factors for mortality in infective endocarditis: a review of 68 cases at a tertiary care center in Turkey.
    Tuğcu A; Yildirimtürk O; Baytaroğlu C; Kurtoğlu H; Köse O; Sener M; Aytekin S
    Turk Kardiyol Dern Ars; 2009 Jan; 37(1):9-18. PubMed ID: 19225248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Juvenile dermatomyositis. Clinical and epidemiologic experience].
    Ott SC; Pozo-Parilli JC; Pagés G; Pizarro CE; Pinto-Plata VM; Pimentel I; Rojas R
    Invest Clin; 1989; 30(1):21-30. PubMed ID: 2489272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Plasma exchange in dermatomyositis. A retrospective study of 21 cases].
    Lok C; Herson S; Roujeau JC; Revuz J; Gérard A; Godeau P
    Ann Dermatol Venereol; 1989; 116(3):219-24. PubMed ID: 2742299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical manifestations, outcomes, and antibody profile of Brazilian adult patients with dermatomyositis: a single-center longitudinal study.
    Truzzi NCC; Hoff LS; Borges IBP; de Souza FHC; Shinjo SK
    Adv Rheumatol; 2022 Nov; 62(1):41. PubMed ID: 36371389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of Nasopharyngeal Carcinoma in Patients with Dermatomyositis: A Systematic Review and Meta-Analysis.
    Irekeola AA; Shueb RH; E A R ENS; Wada Y; Abdul Rahman Z; Ahmad S; Mohamud R; Mat Lazim N; Yean CY
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33919987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.